| Literature DB >> 28032617 |
Stefania Biffi1, Laura Andolfi, Claudia Caltagirone, Chiara Garrovo, Angela M Falchi, Vito Lippolis, Andrea Lorenzon, Paolo Macor, Valeria Meli, Maura Monduzzi, Marc Obiols-Rabasa, Luca Petrizza, Luca Prodi, Antonella Rosa, Judith Schmidt, Yeshayahu Talmon, Sergio Murgia.
Abstract
Herein we provided the first proof of principle for in vivo fluorescence optical imaging application using monoolein-based cubosomes in a healthy mouse animal model. This formulation, administered at a non-cytotoxic concentration, was capable of providing both exogenous contrast for NIR fluorescence imaging with very high efficiency and chemospecific information upon lifetime analysis. Time-resolved measurements of fluorescence after the intravenous injection of cubosomes revealed that the dye rapidly accumulated mainly in the liver, while lifetimes profiles obtained in vivo allowed for discriminating between free dye or dye embedded within the cubosome nanostructure after injection.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28032617 DOI: 10.1088/1361-6528/28/5/055102
Source DB: PubMed Journal: Nanotechnology ISSN: 0957-4484 Impact factor: 3.874